Skip to main content
WGRX
NASDAQ Life Sciences

Wellgistics推出Forzet™以应对GLP-1相关肌肉流失,瞄准700亿美元市场

feedReported by Acceswire
Sentiment info
Positive
Importance info
8
Price
$0.176
Mkt Cap
$14.814M
52W Low
$0.157
52W High
$7.04
Market data snapshot near publication time

summarizeSummary

Wellgistics Health,一家微型健康信息技术公司,已推出Forzet™,一种旨在解决与GLP-1激动剂减重疗法(如Ozempic和Wegovy)相关的肌肉流失的医疗食品。该产品针对迅速增长的GLP-1市场的一个细分领域,预计该市场到2025年将达到700亿美元。Forzet被归类为医疗食品,可在柜台上购买,已在多项临床研究中进行了评估,并将通过公司的附属药店和网络以及其直接面向消费者的产品进行分销。对于一家市值不足1.5亿美元的公司来说,这次产品推向大型和高增长市场的推出代表着一个重大的潜在收入驱动因素和对股票的重大发展。投资者将关注最初的销售数据和采用率,以评估该产品的影响。

在该公告发布时,WGRX的交易价格为$0.18,交易所为NASDAQ,所属行业为Life Sciences,市值约为$1481.4万。 52周交易区间为$0.16至$7.04。 这则新闻被评估为积极市场情绪,重要性评分为8/10。 来源:Acceswire。


show_chartPrice Chart

Share this article

Copied!

feed WGRX - Latest Insights

WGRX
Apr 24, 2026, 4:54 PM EDT
Filing Type: PRE 14A
Importance Score:
9
WGRX
Apr 21, 2026, 4:46 PM EDT
Filing Type: 8-K/A
Importance Score:
9
WGRX
Apr 17, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
WGRX
Apr 15, 2026, 5:23 PM EDT
Filing Type: S-3
Importance Score:
9
WGRX
Apr 14, 2026, 7:05 AM EDT
Source: Access Newswire
Importance Score:
7
WGRX
Apr 09, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
WGRX
Apr 09, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
7
WGRX
Apr 07, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
WGRX
Apr 07, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
9
WGRX
Apr 03, 2026, 10:50 AM EDT
Filing Type: DEF 14C
Importance Score:
8